The impact of weight loss on health-related quality-of-life: Implications for cost-effectiveness analyses

Quality of Life Research

Volumn 23, Issue 4, 2014, Pages 1371-1376

  Rothberg, Amy E ^a   McEwen, Laura N ^a   Kraftson, Andrew T ^a   Neshewat, Gina M ^a   Fowler, Christine E ^a   Burant, Charles F ^a   Herman, William H ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Body mass index; Cost utility analysis; EQ 5D; Health utility score; Obesity; Very low calorie diet

Indexed keywords

AGED; ARTICLE; BEHAVIOR THERAPY; BODY MASS; CALORIC INTAKE; COST BENEFIT ANALYSIS; DIET THERAPY; ECONOMICS; FEMALE; FOLLOW UP; HUMAN; LOW FAT DIET; MALE; METHODOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PAIN ASSESSMENT; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; VISUAL ANALOG SCALE; WEIGHT REDUCTION;

AGED; BEHAVIOR THERAPY; BODY MASS INDEX; COST-BENEFIT ANALYSIS; DIET, FAT-RESTRICTED; ENERGY INTAKE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY; PAIN MEASUREMENT; QUALITY OF LIFE; VISUAL ANALOG SCALE; WEIGHT LOSS;

EID: 84894095400     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-013-0557-8     Document Type: Article

References (22)

1. Gold, M. R.; Siegel, J. E.; Russell, L. B.; Weinstein, M. C. (Eds.). (1996). Cost-effectiveness in health and medicine. New York: Oxford University Press.
2. EQ-5D-5L User Guide. Basic information on how to use the EQ-5D-5L instrument. Version 1.0 April 2011. http://www.euroqol.org/fileadmin/user- upload/Documenten/PDF/Folders-Flyers/UserGuide-EQ-5D-5L.pdf Accessed July 17, 2013.
3. Zhu, S. K.; Wang, Z. M.; Heshka, S.; Heo, M.; Faith, M. S.; Heymsfield, S. B. (2002). Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: Clinical action thresholds. American Journal of Clinical Nutrition, 76, 743-749.
4. Wildman, R. P.; Gu, D.; Reynolds, K.; Duan, X.; He, J. (2004). Appropriate body mass index and waist circumference cutoffs for categorization of overweight and central adiposity among Chinese adults. American Journal of Clinical Nutrition, 80, 1129-1136.
5. WIN Weight-control Information Network. Overweight and obesity statistics. http://www.win.niddk.nih.gov/statistics/ Accessed July 19, 2013.
6. Rothberg, A. E.; Peeters, A. & Herman, W. H. (In press). The cost-effectiveness of obesity prevention and treatment. In G. A. Bray & C. Bouchard (Eds.), Handbook of obesity Vol 2: Clinical applications 4th Edition (pp: In press). London, England: Informa Healthcare.
7. Doyle, S.; Lloyd, A.; Moore, L.; Ray, J.; Gray, A. (2012). A systematic review and critical assessment of health state utilities. Weight change and type 2 diabetes mellitus. Pharmacoeconomics, 30, 1133-1143.
8. Kortt, M. A.; Dollery, B. (2011). Association between body mass index and health-related quality of life among an Australian sample. Clinical Therapeutics, 33, 1466-1474.
9. Dennett, S. L.; Boye, K. S.; Yurgin, N. R. (2008). The impact of body weight on patient utilities with or without type 2 diabetes: A review of the medical literature. Value Health, 11, 478-486.
10. Craig, B. M.; Tseng, D. S. (2002). Cost-effectiveness of gastric bypass for severe obesity. American Journal of Medicine, 113, 491-498.
11. Hakim, Z.; Wolf, A.; Garrison, L. P. (2002). Estimating the effect of changes in body mass index on health state preferences. Pharmacoeconomics, 20, 393-404.
12. Kortt, M. A.; Clarke, P. M. (2005). Estimating utility values for health states of overweight and obese individuals using the SF-36. Quality of Life Research, 14, 2177-2185.
13. Soltoft, F.; Hammer, M.; Kragh, N. (2009). The association of body mass index and health-related quality of life in the general population: Data from the 2003 Health Survey of England. Quality of Life Research, 18, 1293-1299.
14. Trakas, K.; Oh, P. I.; Singh, S.; et al. (2001). The health status of obese individuals in Canada. International Journal of Obesity and Related Metabolic Disorders, 25, 662-668.
15. Livingston, E. H.; Ko, C. Y. (2002). Use of the health and activities limitation index as a measure of quality of life in obesity. Obesity Research, 10, 824-832.
16. Groessl, E. J.; Kaplan, R. M.; Barrett-Connor, E.; et al. (2004). Body mass index and quality of well-being in a community of older adults. American Journal of Preventive Medicine, 26, 126-129.
17. Macran, S. (2004). The relationship between body mass index and health-related quality of life. Centre for Health Economics: University of York.
18. Sach, T. H.; Barton, G. R.; Doherty, M.; et al. (2007). The relationship between body mass index and health-related quality of life: Comparing the EQ-5D, EuroQol VAS and SF-6D. International Journal of Obesity (London), 31, 189-196.
19. Brennan, A.; Ara, R.; Sterz, R.; et al. (2006). Assessment of clinical and economic benefits of weight management with sibutramine in general practice in Germany. The European Journal of Health Economics, 7, 276-284.
20. Ara, R.; Brennan, A. (2007). The cost-effectiveness of sibutramine in non-diabetic obese patients: Evidence from four Western countries. Obesity Reviews, 8, 363-371.
21. Kolotkin, R. L.; Norquist, J. M.; Crosby, R. D.; et al. (2009). One-year health-related quality of life outcomes in weight loss trial participants: Comparison of three measures. Health Qual Life Outcomes,. doi: 10.1186/1477-7525-7-53.
22. Janssen, M. F.; Pickard, A. S.; Golicki, D.; Gudex, C.; Niewada, M.; Scalone, L.; et al. (2012). Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: A multi-country study. Quality of Life Research,. doi: 10.1007/s11136-012-0322-4.